Clinical Trials Browser

Unknown × Interventional × Clear all

NCT01107522 2025-09-09

Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With Temodar® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant Gliomas

Phase 1 Unknown

Glioblastoma, Glioma

NCT02223923 2025-08-01

Patriot

Phase 1 Unknown

Other solid neoplasm

Solid Tumour Refractory to Conventional Treatment

NCT02716012 2025-03-10

OUTREACH

Phase 1 Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT02637479 2025-01-30

Hyporadoul

Phase NA Unknown

Any Cancer With Multiple Bone Metastases

NCT06216743 2024-12-31

PRE-MISTIC

Phase NA Unknown

Gastrointestinal

Colonic Neoplasms

NCT06250244 2024-12-11

177Lu-LNC1011 in Patients with Metastatic Castration-resistant Prostate Cancer

Phase 1/2 Unknown

Metastatic Castration-resistant Prostate Cancer

NCT04432207 2024-11-07

A Study of IMU-201 (PD1-Vaxx), a B-Cell Immunotherapy, in Adults with Non-Small Cell Lung Cancer

Phase 1 Unknown

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung

NCT06678230 2024-11-07

Clinical Trial of Eribulin in Combination with Anrotinib for HER-2 Negative Locally Advanced or Metastatic Breast Cancer

Phase 2 Unknown

Breast Neoplasms

NCT06659406 2024-10-26

PCOS

Phase NA Unknown

Polycystic Ovary Syndrome

NCT02236910 2024-10-15

Lu-DOTA-TATE

Phase 2 Unknown

Carcinoma, Neuroendocrine

NCT06121752 2024-10-15

DNET

Phase NA Unknown

Neuroendocrine Tumors

NCT04977167 2024-10-10

Clinical Trial of HG146 Administered to Subjects with Advanced Solid Tumors or Lymphoma

Phase 1 Unknown

Lymphoma

NCT05763004 2024-10-08

A Clinical Study to Evaluate the Safety, Tolerability and Efficacy of IOS-1002 Administered Alone and in Combination with Pembrolizumab, a PD-1 Monoclonal Antibody in Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor, Adult

NCT05644821 2024-10-01

PRO-P

Phase NA Unknown

Prostatic Neoplasms

NCT03310632 2024-09-25

Determine Function of Antroquinonol in Combination With SOC in First Line Metastatic Pancreatic Cancer

Phase 1/2 Unknown

Gastrointestinal

Pancreatic Neoplasms

NCT05625737 2024-09-19

Fruquintinib Combined with Sintilimab As Second-line Therapy for Gastric or Gastro-esophageal Junction Adenocarcinoma

Phase 2 Unknown

Gastrointestinal

Stomach Neoplasms

NCT05830097 2024-08-26

A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors

Phase 1/2 Unknown

BreastGastrointestinalThoracic

Breast Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Pancreatic Neoplasms

NCT06566391 2024-08-22

Ipilimumab and Nivolumab Followed by Adjuvant Nivolumab in Locally Advanced or Limited Metastatic Melanoma

Phase 2 Unknown

Melanoma

NCT04354233 2024-08-21

ABLE02

Phase NA Unknown

Breast Neoplasms, Fatigue, Motor Activity

NCT05452668 2024-08-21

Laser Therapy Effect on Oral Mucositis in Childhood Acute Lymphoblastic Leukemia Patients

Phase NA Unknown

LymphoidOther hematologic neoplasm

Stomatitis, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03612232 2024-08-19

CaboACC

Phase 2 Unknown

Adrenal Cortex Neoplasms, Adrenal Gland Neoplasms, Adrenocortical Carcinoma

NCT06556004 2024-08-15

Trimelvax001

Phase 1 Unknown

Melanoma

NCT06157359 2024-08-09

Effect of SNB on the QoR in Patients Undergoing Supratentorial Tumor Resection

Phase NA Unknown

Supratentorial Neoplasms

NCT04922658 2024-07-31

Surufatinib or Surufatinib Combined With Vinorelbine for Non-Small Cell Lung Cancer

Phase 2 Unknown

Advanced Non-Small Cell Lung Cancer

NCT06128694 2024-07-30

Effect of NUTRICAN to Improve Nutritional Status in Cancer Patients

Phase 3 Unknown

GynecologicThoracic

Uterine Cervical Neoplasms, Kwashiorkor, Lung Neoplasms, Neoplasms, Malnutrition

NCT06526832 2024-07-30

A Phase 1 Study of BST02 in Treating Locally Advanced Liver Cancer

Phase 1 Unknown

Locally Advanced Liver Carcinoma

NCT06199908 2024-07-26

AMT-562 in Patients With Selected Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Advanced Solid Tumors

NCT03362801 2024-07-19

SAMPHYR

Phase NA Unknown

Urinary Bladder Neoplasms, Motor Activity, Sarcopenia

NCT05183243 2024-07-16

GH21 Capsules for Advanced Solid Tumors: A Study on Safety and Early Results

Phase 1 Unknown

GastrointestinalHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

NCT04939883 2024-06-28

CardioTox

Phase 4 Unknown

Neoplasms, Cardiotoxicity

NCT05240625 2024-06-20

Clinical Efficacy Evaluation of a Computer-aided Colonoscopy as Compared With the Standard Colonoscopy.

Phase NA Unknown

Gastrointestinal

Colorectal Neoplasms

NCT05155618 2024-06-18

MicroStyle

Phase NA Unknown

Motor Activity, Prostatic Neoplasms

NCT03818386 2024-06-14

NANORAD2

Phase 2 Unknown

Brain Neoplasms

NCT05832892 2024-06-14

Surufatinib Combined With KN046 and AG Regimen Chemotherapy as First-Line Treatment for Unresectable Advanced Pancreatic Cancer

Phase 1/2 Unknown

Gastrointestinal

Pancreatic Neoplasms

NCT05457010 2024-06-12

Phase I Study of Cell Therapies for the Treatment of Patients With Relapsed or Refractory AML or High-risk MDS

Phase 1 Unknown

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT06270706 2024-06-12

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Phase 1 Unknown

BreastDermatologicGastrointestinalGenitourinaryGynecologic

Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Melanoma, Neoplasm Metastasis, Colorectal Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT06455722 2024-06-12

[68Ga]Ga-P15-041 PET/CT in Variety of Bone Tumors

Phase EARLY_PHASE1 Unknown

Bone Neoplasms

NCT05638451 2024-06-05

Sintilimab in Combination With Bevacizumab and Temozolomide in Recurrent Glioblastoma (GBM) Patients

Phase 2 Unknown

Glioblastoma

NCT04547634 2024-06-04

Telerehabilitation in Oncology Patients

Phase NA Unknown

COVID-19, Neoplasm Metastasis, Neoplasms

NCT06136065 2024-06-04

FAPI

Phase 2 Unknown

Other solid neoplasm

Solid Tumor, Unspecified, Adult

NCT06435741 2024-05-30

Molecular Imaging of Gastric Cancer Metastatic Lymph Nodes with 99mTc-3PRGD2 Probe.

Phase NA Unknown

Gastrointestinal

Lymphatic Metastasis, Stomach Neoplasms

NCT03921671 2024-05-29

RELEVENT

Phase 2 Unknown

Neoplasm Metastasis, Thymoma

NCT05605197 2024-05-28

U87 CART in Treatment of Advanced Solid Tumor

Phase 1 Unknown

Gastrointestinal

Pancreatic Neoplasms

NCT05075356 2024-05-14

iToBoS

Phase NA Unknown

Disease, Melanoma

NCT01516710 2024-05-10

Oslo-CoMet

Phase NA Unknown

280 enrolled 8 charts

Gastrointestinal

Colorectal Neoplasms

NCT04159974 2024-05-09

RICE

Phase 2 Unknown

Gastrointestinal

Adenocarcinoma Of Esophagus

NCT06406673 2024-05-09

A Phase II Clinical Study of Cadonilimab in Treatment-naïve or Relapsed Extensive Small Cell Lung Cancer

Phase 2 Unknown

Extensive Small Cell Lung Cancer

NCT06405685 2024-05-08

Nimotuzumab Plus AG in Pancreatic Cancer With Liver Metastasis

Phase 2 Unknown

Gastrointestinal

Pancreatic Neoplasms

NCT06395337 2024-05-02

MIRCA & MIPAC

Phase 1/2 Unknown

Gastrointestinal

Pancreatic Neoplasms, Rectal Neoplasms

NCT04557020 2024-05-01

Adding PD-1 Inhibitor to Neoadjuvant and Adjuvant for NPC

Phase 3 Unknown

Nasopharyngeal Carcinoma